JAMA 331:654664 [DOI] [PMC free article] [PubMed] [Google Scholar] 6.Perdomo CM, Cohen RV, Sumithran P, Clment K, Frhbeck G (2023) Contemporary medical, device, and surgical therapies for obesity in adults
In one of the initial long-term pivotal studies of patients with type 1 and insulin-requiring T2D where full-dose pramlintide was added to existing insulin regimens in double-blind fashion without titration, it was observed that the severe hypoglycemia event rate during the first 4 weeks of therapy was higher in the pramlintide group compared with the placebo group
Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
E.FabbriniE.et al (2012)
Information is also available through ClinicalTrials.gov and the ISRCTN registry , or by speaking with a specialist obesity medicine physician or endocrinologist
Mozzarella delivers calcium and fat to support vitamin absorption
